基本信息
浏览量:117
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Dr. Wen-Kai Weng specializes in the treatment of non-Hodgkin's lymphoma (NHL), his basic research interest is immunotherapy for lymphoma and cancer, with two components: tumor specific targeting therapy and allogeneic transplant. He is currently working on new strategies to target patient-specific tumor using antibody along with effector cells. He is also conducting clinical study looking at the clinical efficacy of allogeneic transplant in patients with cutaneous lymphoma.
研究兴趣
论文共 187 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
BLOOD ADVANCESno. 6 (2024): 1474-1486
Jay Spiegel,Jean S. Oak,Anmol Goyal, Scott Bornheimer, Allison Irvine,Rhine R. Shen,Katherine A. Kong,Sushma Bharadwaj,Wen-Kai Weng,Melody Smith,Matthew J. Frank,Saurabh Dahiya,
Transplantation and Cellular Therapyno. 2 (2024): S204
Mark P. Hamilton,Erin Craig, Cesar Gentille, Alain Mina,John Tamaresis, Nadia Kirmani, Zachary Ehlinger,Shriya Syal, Zinaida Good,Brian Sworder, Joseph Schroers-Martin,Ying Lu,
Blood Advancesno. 12 (2024): 3314-3326
Blood advancesno. 12 (2024): 3001-3012
Blood Advances (2024)
Sushma Bharadwaj,Eric Lau,Mark P Hamilton,Anmol Goyal, Hrishi Srinagesh,Alexandria Jensen,Dasom Lee, Jayasindhu Mallampet, Sarah Elkordy,Shriya Syal,Sunita Patil,Theresa Latchford,
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn